Brief: Idorsia Released From Exclusivity Constraint Regarding Global Rights To Aprocitentan
26/02/2025 05:51
Feb 26 (Reuters) - Idorsia Ltd IDIA.S: IDORSIA LTD - RELEASED FROM EXCLUSIVITY CONSTRAINT REGARDING GLOBAL RIGHTS TO APROCITENTAN - NOW PIVOTING TO ALTERNATIVE PARTIES IDORSIA LTD - WILL RETAIN EXCLUSIVITY FEE OF USD 35 MILLION PAID IN DECEMBER 2024 Source text: ID:nGNE633jRw Further company coverage: IDIA.S (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))